DOD Biotech Public Company Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was THB 248.124 million compared to THB 226.310 million a year ago. Operating income was THB 14.722 million compared to THB 64.043 million a year ago. Net loss was THB 57.833 million compared to net income of THB 75.735 million a year ago. Basic loss per share was THB 0.14 compared to basic earnings per share of THB 0.18 a year ago. Basic earnings per share from continuing operations was THB 0.04 compared to THB 0.15 a year ago. For the half year, total revenue was THB 604.023 million compared to THB 407.753 million a year ago. Operating income was THB 177.498 million compared to THB 79.791 million a year ago. Net loss was THB 2.704 million compared to net income of THB 103.692 million a year ago. Basic loss per share was THB 0.01 compared to basic earnings per share of THB 0.25 a year ago. Basic earnings per share from continuing operations was THB 0.43 compared to THB 0.2 a year ago.